BioSpace News Archive

LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022

LifeTech Scientific Corporation, a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, announced its 2022 annual results.

March 29, 2023
·
6 min read
Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial

Apex Labs Ltd. (APEX or the Company) is pleased to announce the completion of the first-ever take home microdose psilocybin clinical trial, meeting all endpoints over a two month period with no adverse events.

March 29, 2023
·
5 min read
Transcenta’s Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer

Transcenta Holding Limited announces that the U.S. Food and Drug Administration has granted Orphan Drug Designation to Osemitamab, its high affinity humanized ADCC-enhanced anti-Claudin18.2 monoclonal antibody, for the treatment of patients with pancreatic cancer.

March 29, 2023
·
5 min read
SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations

SciBase Holding AB, a leading developer of augmented intelligence-based solutions for skin disorders announced that they have entered into a collaboration agreement with Schweiger Dermatology group to pilot Nevisense in their Freehold, NJ office.

March 29, 2023
·
3 min read
Medigene AG Reports Full-Year 2022 Financial Results and Provides Corporate Update

Medigene AG, an early stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, reported financial results for the year ended December 31, 2022 and provided a corporate update.

March 29, 2023
·
7 min read
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment

Pharmaron Beijing Co., Limited announced that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s Life Sciences Innovation Manufacturing Fund to expand their viral vector and DNA manufacturing facilities for more than 8,000 sqM.

March 29, 2023
·
3 min read
Biotech Bay

Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas

Mainz Biomed NV announced results of an independent feasibility study conducted in collaboration with members of the Early Detection Research Network to evaluate the Company’s portfolio of five novel gene expression biomarkers acquired from Université de Sherbrooke in January, 2022.

March 29, 2023
·
10 min read
Business

Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

Synlogic, Inc., the leading company advancing therapeutics based on synthetic biology, reported financial results for the fourth quarter and full year ending December 31, 2022 and provided a business update.

March 29, 2023
·
8 min read
Business

BiomX Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

BiomX Inc., a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2022.

March 29, 2023
·
10 min read
Genetown

Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference

Entrada Therapeutics, Inc. today announced that Dipal Doshi, President and Chief Executive Officer, will participate in a virtual fireside chat during the Guggenheim Genomic Medicines and Rare Disease Conference on Tuesday, April 4, 2023 at 9:00 a.m. Eastern Time.

March 29, 2023
·
1 min read